Jupiter NeurosciencesJUNS
13F holders, Q2 2025 (June 30)2holders −5
0new positions
5sold out
$1.02avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Jupiter Neurosciences Inc. (JUNS) in their 13F filings, down 5 from Q1 2025. 0 opened new positions and 5 sold out. The largest holders were UBS Group AG ($55K) and Citigroup Inc. ($11K).
- Company
- Jupiter Neurosciences Inc.
- CUSIP
- 48208B203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 5 | $79K |
All 13F filers, Q1 2025 → Q2 2025: 312,953 shares sold, net −312,953 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| UBS Group AG | 0.00% | Reduce -60.3% | 53,916 | $55K |
| Citigroup Inc. | 0.00% | Reduce -90.1% | 11,106 | $11K |
"% of holder's portfolio" is JUNS's weight in each manager's 13F, not the share of Jupiter Neurosciences Inc. the manager owns.